Background: Mirizzi syndrome is a condition, difficult to diagnose pre-operatively and treat, represent a particular challenge for hepatobiliary surgeons. Furthermore, it increases the risk of intra-operative biliary injury, particularly during laparoscopic cholecystectomy. The aims of this study were to point out some particular aspect of diagnosis and treatment of this condition that will be helpful for the surgeons.
Introduction
Mirizzi syndrome was first described by one of the major biliary surgeons of past century, Pablo Luis Mirizzi in 1948. This syndrome is an uncommon complication of chronic gall stone disease. Pathophysiologically, this condition involves extrinsic
Csendes classification of Mirizzi syndrome
Type Description Type I Type I (A) Extrinsic compression in the common hepatic duct (CHD), caused by stone impacted in the cystic duct or in the infundibulum Type I (B) Absence of cystic duct (5) Type II Presence of cholecystocholedochal biliary fistula involving one third of the circumference of the CHD wall
Type III Presence of cholecystocholedochal biliary fistula with a diameter over two thirds of the CHD wall 
Results
From January 2013 to January 2018, a total of 1320 cholecystectomy were performed, out of which 50 patients were diagnosed with Mirizzi syndrome representing an incidence rate of 3.78%. Male to female ratio was 0.72:1 and mean age was 54.14 years. Characteristics are shown in Table I There was no postoperative mortality. Morbidity included two cases of biliary fistula that resolved with conservative management and another case that required percutaneous treatment for resolution of an intraperitoneal postoperative collection.
The average post-operative follow up was 9±3 months but 3 patients were lost to follow up. After the histopathological study of surgical specimen, we found one case of gall bladder carcinoma in stage T2A in which oncological resection was done in second surgery. 
Discussion
The frequency of Mirizzi syndrome presented in different series of cholelithiasis is highly variable: less than 1% in western countries and around 4.5% in developing countries. 5 In our study, this percentage is high, because of the bias being a surgical unit in tertiary hospitals, where a large number of patients with complex biliary disease are being admitted.
Mirizzi syndrome is a difficult disease to diagnose because of the absence of pathognomonic sign and symptoms. Characteristically the is often disease scarce and occur often as an intermittent jaundice, an unexpected findings in the course of laparoscopic cholecystectomy or starts in Boulder et syndrome. 6 In our series preoperative diagnosis was 80% and jaundice was the main sign. Therefore, it is important to have Mirizzi syndrome in differential diagnosis of obstructive jaundice.
In the literature, the idea that majority of patients present pain in episodic or right upper quadrant (60% to 100%), jaundice (50% to 100%) and elevated liver enzymes (10%) is reinforced. In our series the most common two features were jaundice and abdominal pain.
Cholangitis has also been referred as initial abut of Mirizzi syndrome. The mean age of presentation of Mirizzi syndrome was high in our series in comparison to other studies. 7 It is noteworthy that in recent years, we are experiencing an increased number of cholecystectomy in older patients with gallstone because of increased life expectancy.
Adequate preoperative diagnosis with meticulous surgical planning is vital for the management of Mirizzi syndrome. Unfortunately, this preliminary diagnosis only can be made in 18% to 62% of patients. 8 A fundamental aspect to note in our study is that this number could increase (80% in our study) with the support of MRCP, ERCP and computed tomography scan which allowed a more selective, programmed and laparoscopic approach. This possibly contributed to minimize postoperative complications related to the biliary tract.
ERCP is useful in assessing the existence of a cholecystobiliary fistula. However, it has sensitivity of over 55% and a significant morbidity and not all patient in our series met the criteria of ERCP. Endoscopic treatment of Mirizzi syndrome includes with stenting or prosthesis to relieve jaundice and allow elective surgery. It is also used in removal of CBD stones with a balloon or dorm basket. 9 Current evidence suggests that laparoscopy can not be recommended as a standard procedure in Mirizzi syndrome. In fact preoperative diagnosis of the syndrome is an important predictor the success of the approach, especially in type I and type II. 2 This approach remains controversial because of high rates of conversion. 10, 11 Most authors suggest that type I Mirizzi syndrome is ideal for minimal invasive approach. 8 Faced with type I Mirizzi syndrome, treatment of choice is laparoscopic cholecystectomy with retrograde dissection of the gall bladder. As mentioned subtotal cholecystectomy is an safe and easy option and definitive strategy in more complex approach especially in case of cirrhotic liver with portal hypertension. 2 Faced with type II Mirizzi syndrome, treatment depends upon the severity of fistula and involvement of the surrounding tissues. In few cases, it is required to perform a partial cholecystectomy, with using the remaining wall of cystic duct or gall bladder wall to repair the fistula with T tube placement. This option is the most useful if the surrounding tissue is healthy. 12 The Roux en Y hepatico-jejunostomy is the safest option for in case of bile duct tissue ischemia. Some authors reported that type Mirizzi syndrome could treated with laparoscopic cholecystectomy and ERCP stenting. 13 The stent would overcome the resistance of the sphincter and allow the repaired fistula to heal. 14 The prognosis is extreme favorable in type I Mirizzi syndrome, as it is solved with simple cholecystectomy. Post-operative morbidity increase with treatment of severe types (II, III, IV).
Conclusion
In our study, management of Mirizzi syndrome ranges from laparoscopic cholecystectomy to Roux en Y hepatoco-jejunostomy. Pre-operative imaging specially MRCP has high sensitivity which can help in operative strategy. ERCP is helpful for certain conditions where MRCP could not delineate the biliary anatomy clearly. Laparoscopic approach should be reserved for type I and open for rest of occasions by Roux en Y hepaticojejunostomy mostly. Few cases for type II can be subtotal cholecystectomy and fistula repair. Nevertheless, for the diagnosis and treatment of Mirizzi syndrome whether old or new studies are limited by small sample size and therefore studies with larger sample size is required to set a clear guideline for management of Mirizzi syndrome.
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